Namibia vs Pre-demographic dividend: Current health expenditure
Current health expenditure over time
- Namibia
- Pre-demographic dividend
How they compare
Namibia currently reports 9.5% against 4.5% in Pre-demographic dividend, a difference of 5.0%.
That makes Namibia's figure about 2.1 times Pre-demographic dividend's.
Across all 24 years both countries report, Namibia has been ahead every year.
Namibia ranks 35th and Pre-demographic dividend ranks 38th of 193 countries.
Namibia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Namibia | Pre-demographic dividend | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.7% | 4.0% | 6.7% | Namibia |
| 2010s | 9.6% | 3.8% | 5.7% | Namibia |
| 2020s | 9.7% | 4.4% | 5.3% | Namibia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher current health expenditure, Namibia or Pre-demographic dividend?
- Namibia, at 9.5% against 4.5% in Pre-demographic dividend as of 2023.
- What is the difference in current health expenditure between Namibia and Pre-demographic dividend?
- 5.0%, with Namibia ahead.
- How many years of comparable data are there for Namibia and Pre-demographic dividend?
- 24 years are reported by both, from 2000 to 2023.
- How do Namibia and Pre-demographic dividend rank globally for current health expenditure?
- Namibia ranks 35th and Pre-demographic dividend ranks 38th of 193 countries.
- Where does this data come from?
- Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO), published as Current health expenditure (% of GDP). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Level of current health expenditure expressed as a percentage of GDP. Estimates of current health expenditures include healthcare goods and services consumed during each year. This indicator does not include capital health expenditures such as buildings, machinery, IT and stocks of vaccines for emergency or outbreaks.